176 related articles for article (PubMed ID: 17194595)
21. Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists.
Gong Y; Barbay JK; Dyatkin AB; Miskowski TA; Kimball ES; Prouty SM; Fisher MC; Santulli RJ; Schneider CR; Wallace NH; Ballentine SA; Hageman WE; Masucci JA; Maryanoff BE; Damiano BP; Andrade-Gordon P; Hlasta DJ; Hornby PJ; He W
J Med Chem; 2006 Jun; 49(11):3402-11. PubMed ID: 16722660
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase.
Chand P; Kotian PL; Morris PE; Bantia S; Walsh DA; Babu YS
Bioorg Med Chem; 2005 Apr; 13(7):2665-78. PubMed ID: 15755666
[TBL] [Abstract][Full Text] [Related]
23. New beta-alanine derivatives are orally available glucagon receptor antagonists.
Lau J; Behrens C; Sidelmann UG; Knudsen LB; Lundt B; Sams C; Ynddal L; Brand CL; Pridal L; Ling A; Kiel D; Plewe M; Shi S; Madsen P
J Med Chem; 2007 Jan; 50(1):113-28. PubMed ID: 17201415
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors.
Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S
Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447
[TBL] [Abstract][Full Text] [Related]
25. Discovery of 4-[1-[([1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl]carbonyl)amino]cyclopropyl]benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain.
Colucci J; Boyd M; Berthelette C; Chiasson JF; Wang Z; Ducharme Y; Friesen R; Wrona M; Levesque JF; Denis D; Mathieu MC; Stocco R; Therien AG; Clarke P; Rowland S; Xu D; Han Y
Bioorg Med Chem Lett; 2010 Jun; 20(12):3760-3. PubMed ID: 20471829
[TBL] [Abstract][Full Text] [Related]
26. Pyridone derivatives as potent and selective VLA-4 integrin antagonists.
Witherington J; Bordas V; Gaiba A; Green PM; Naylor A; Parr N; Smith DG; Takle AK; Ward RW
Bioorg Med Chem Lett; 2006 Apr; 16(8):2256-9. PubMed ID: 16455247
[TBL] [Abstract][Full Text] [Related]
27. Identification of trans-4-[1-[[7-fluoro-2-(1-methyl-3-indolyl)-6-benzoxazolyl]acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid as a potent, orally active VLA-4 antagonist.
Setoguchi M; Iimura S; Sugimoto Y; Yoneda Y; Chiba J; Watanabe T; Muro F; Iigo Y; Takayama G; Yokoyama M; Taira T; Aonuma M; Takashi T; Nakayama A; Machinaga N
Bioorg Med Chem; 2012 Feb; 20(3):1201-12. PubMed ID: 22261021
[TBL] [Abstract][Full Text] [Related]
28. N-Tetrahydrofuroyl-(L)-phenylalanine derivatives as potent VLA-4 antagonists.
Yang GX; Chang LL; Truong Q; Doherty GA; Magriotis PA; de Laszlo SE; Li B; MacCoss M; Kidambi U; Egger LA; McCauley E; Van Riper G; Mumford RA; Schmidt JA; Hagmann WK
Bioorg Med Chem Lett; 2002 Jun; 12(11):1497-500. PubMed ID: 12031328
[TBL] [Abstract][Full Text] [Related]
29. 2,6-Quinolinyl derivatives as potent VLA-4 antagonists.
Lassoie MA; Broeders F; Collart P; Defrère L; de Laveleye-Defais F; Demaude T; Gassama A; Guillaumet G; Hayez JC; Kiss L; Knerr L; Nicolas JM; Norsikian S; Quéré L; Routier S; Verbois V; Provins L
Bioorg Med Chem Lett; 2007 Jan; 17(1):142-6. PubMed ID: 17035017
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization and evaluation of pro-drugs of VLA-4 antagonists.
Huryn DM; Ashwell S; Baudy R; Dressen DB; Gallaway W; Grant FS; Konradi A; Ley RW; Petusky S; Pleiss MA; Sarantakis D; Semko CM; Sherman MM; Tio C; Zhang L
Bioorg Med Chem Lett; 2004 Apr; 14(7):1651-4. PubMed ID: 15026043
[TBL] [Abstract][Full Text] [Related]
31. 2,3-Diphenylpropionic acids as potent VLA-4 antagonists.
Hoshina Y; Ikegami S; Okuyama A; Fukui H; Inoguchi K; Maruyama T; Fujimoto K; Matsumura Y; Aoyama A; Harada T; Tanaka H; Nakamura T
Bioorg Med Chem Lett; 2005 Jan; 15(1):217-20. PubMed ID: 15582442
[TBL] [Abstract][Full Text] [Related]
32. The discovery of 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonist.
Blouin M; Han Y; Burch J; Farand J; Mellon C; Gaudreault M; Wrona M; Lévesque JF; Denis D; Mathieu MC; Stocco R; Vigneault E; Therien A; Clark P; Rowland S; Xu D; O'Neill G; Ducharme Y; Friesen R
J Med Chem; 2010 Mar; 53(5):2227-38. PubMed ID: 20163116
[TBL] [Abstract][Full Text] [Related]
33. The discovery of acylated beta-amino acids as potent and orally bioavailable VLA-4 antagonists.
Lin LS; Kopka IE; Mumford RA; Magriotis PA; Lanza T; Durette PL; Kamenecka T; Young DN; de Laszlo SE; McCauley E; Riper GV; Kidambi U; Egger LA; Tong X; Lyons K; Vincent S; Stearns R; Colletti A; Teffera Y; Fenyk-Melody J; Schmidt JA; MacCoss M; Hagmann WK
Bioorg Med Chem Lett; 2002 Feb; 12(4):611-4. PubMed ID: 11844683
[TBL] [Abstract][Full Text] [Related]
34. Substituted N-(3,5-dichlorobenzenesulfonyl)-L-prolyl-phenylalanine analogues as potent VLA-4 antagonists.
Kopka IE; Young DN; Lin LS; Mumford RA; Magriotis PA; MacCoss M; Mills SG; Van Riper G; McCauley E; Egger LE; Kidambi U; Schmidt JA; Lyons K; Stearns R; Vincent S; Colletti A; Wang Z; Tong S; Wang J; Zheng S; Owens K; Levorse D; Hagmann WK
Bioorg Med Chem Lett; 2002 Feb; 12(4):637-40. PubMed ID: 11844689
[TBL] [Abstract][Full Text] [Related]
35. Discovery of a potent, orally available, and isoform-selective retinoic acid beta2 receptor agonist.
Lund BW; Piu F; Gauthier NK; Eeg A; Currier E; Sherbukhin V; Brann MR; Hacksell U; Olsson R
J Med Chem; 2005 Dec; 48(24):7517-9. PubMed ID: 16302793
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists.
Gilligan PJ; Clarke T; He L; Lelas S; Li YW; Heman K; Fitzgerald L; Miller K; Zhang G; Marshall A; Krause C; McElroy JF; Ward K; Zeller K; Wong H; Bai S; Saye J; Grossman S; Zaczek R; Arneric SP; Hartig P; Robertson D; Trainor G
J Med Chem; 2009 May; 52(9):3084-92. PubMed ID: 19361209
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of a series of potent and orally bioavailable thrombin inhibitors that utilize 3,3-disubstituted propionic acid derivatives in the P3 position.
Tucker TJ; Lumma WC; Lewis SD; Gardell SJ; Lucas BJ; Sisko JT; Lynch JJ; Lyle EA; Baskin EP; Woltmann RF; Appleby SD; Chen IW; Dancheck KB; Naylor-Olsen AM; Krueger JA; Cooper CM; Vacca JP
J Med Chem; 1997 Oct; 40(22):3687-93. PubMed ID: 9357536
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a novel series of benzoic acid derivatives as potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. 3. Phenylethanolaminotetraline (PEAT) skeleton containing biphenyl or biphenyl ether moiety.
Imanishi M; Nakajima Y; Tomishima Y; Hamashima H; Washizuka K; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F; Hattori K
J Med Chem; 2008 Aug; 51(15):4804-22. PubMed ID: 18651730
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships of novel, highly potent, selective, and orally active CCR1 antagonists.
Xie YF; Lake K; Ligsay K; Komandla M; Sircar I; Nagarajan G; Li J; Xu K; Parise J; Schneider L; Huang D; Liu J; Dines K; Sakurai N; Barbosa M; Jack R
Bioorg Med Chem Lett; 2007 Jun; 17(12):3367-72. PubMed ID: 17446072
[TBL] [Abstract][Full Text] [Related]
40. 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokinetics.
Borthwick AD; Davies DE; Exall AM; Livermore DG; Sollis SL; Nerozzi F; Allen MJ; Perren M; Shabbir SS; Woollard PM; Wyatt PG
J Med Chem; 2005 Nov; 48(22):6956-69. PubMed ID: 16250654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
